Immunoglobulin, Diagnosis, Evaluation, and Key Learnings Patient Registry (IDEaL™)

Completed

Conditions studied: IVIg or SCIg Therapy in the Home or at Alternate Site

In brief

The IDEaL registry is a cooperative, observational registry focused on immunoglobulin use in the U.S. The registry is a deliberate and purposeful assembly of clinical and humanistic knowledge that is intended to act as a longitudinal database, tracking outcomes of routine clinical practice. The central goal of the registry is to provide a mechanism that allows for a better understanding of how immunoglobulin therapy is being used in a real-world clinical setting. The data gathered will help the industry gain a better understanding surrounding the therapeutic value of immunoglobulin therapy and subsequently improve practices, reduce medical costs, and ultimately improve the clinical outcomes for the patients receiving immunoglobulin therapy

Key facts

Study ID

NCT01109810

Run by

Coram Clinical Trials

People needed

496

Starts

2010-09-08

Expected to finish

2022-06-10

Last updated by the study team

2022-06-22

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Signed informed consent
• Any age, disease, or gender requiring Ig therapy
• Agree to the use of Coram's infusion services after entry into IDEaL Registry

You may not qualify if…

• Unable to start, or stops taking Ig therapy
• Use of an insurance provider for which Coram's services are not covered/authorized.
• Have previously participated in the IDEaL Registry and revoked consent to use their PHI

Where it is running

• Coram Clinical Trials — Centennial, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.